Updated 21 September 2026

Quality workflow buying guide

Complaint management software: follow the issue beyond the customer reply

A customer has received a replacement and the support ticket is closed. Then another report describes the same symptom. Can your quality team recover the original evidence, distinguish a duplicate report from a new occurrence and review whether the previous action worked? Use that sequence to evaluate complaint software.

Jump to the 16 products

Editorial responsibility: Dimitris Mitsios (Founder of The QHSE Standard; product marketing at Tekmon) · Tekmon pays for sponsored placements on this site (disclosure) · How pages are made · LinkedIn

Guide sources checked 21 September 2026. This is an unranked documentation review with proposed demos, not hands-on product testing. Profiles retain their separate commercial and capability review dates. Evaluation methodology.

TekmonAd

Explore its published safety, quality and maintenance workflows. Confirm modules and pricing in a scoped proposal.

Keep four decisions separate

Decision	Evidence to retain	What the status does not establish
Customer response	Acknowledgement, reply, replacement or other agreed response	Closing the support ticket does not finish the quality investigation.
Quality investigation	Reported issue, identifiers, evidence, findings and review rationale	A complaint alleges a problem; a confirmed nonconformance needs evidence against a requirement.
CAPA escalation and effectiveness	Reason for escalation or no escalation, actions and later effectiveness review	Every complaint does not automatically require a separate CAPA; task completion does not prove effectiveness.
Regulatory reporting, where applicable	Jurisdiction, product, reporting role, assessment, due-date basis and submission evidence	A generated form or closed complaint is not proof of a completed reporting obligation.

Documented complaint scopes to investigate

These are quality and postmarket workflows, rather than a general customer-service ticket shortlist. Match the named application to your product, industry and review process.

The cards open the broader product profiles. Their pricing and connectivity evidence retain the dates shown there; neither a general QMS subscription nor a mobile claim establishes the complete complaint workflow.

Tekmon pays for a sponsored placement (above); its place in this list follows the same rule as every entry. How lists are ordered

Same rule for every product: tagged “Complaint Management”, “Quality Management” or “CAPA Management”, with a sourced complaint handling capability in its record, or one the vendor stated to us, labelled as vendor-stated. 16 qualify; the first 8 are shown, then the other 8.

Effivity
Documented: Customer complaint lifecycle. Source: effivity.com
SimplerQMS
Documented: Connected quality-event intake. Source: simplerqms.com
1factory
Documented: NCR, CAPA, SCAR and complaint workflows (conditional). Source: 1factory.com
Greenlight Guru
Greenlight Guru complaint handling: Medical-device feedback linked to quality, design and risk. Greenlight Guru describes feedback and complaint records, review tasks, links to design/risk information and escalation of systemic issues to CAPA. Investigate when postmarket feedback needs to inform the device quality and development record. Verify in the demo: The complaint page describes assigning a task to generate an FDA report. That alone does not establish direct electronic submission or receipt. Quote the required quality/development scope; Clinical remains a separate offering. Source: greenlight.guru
isoTracker
Documented: Non-conformance and complaints. Source: isotracker.com
qmsWrapper
Documented: Complaints, supplier and training records (conditional). Source: qmswrapper.com
Scilife
Documented: Quality events and investigations. Source: scilife.io
AssurX
AssurX Complaint Management: Configurable complaint review within an enterprise QMS. AssurX describes intake, triage, investigation tasks, decision rules and connections to other quality processes. Its CAPA page separately documents effectiveness checks. Investigate when complaint handling needs a controlled handoff to quality actions. Verify in the demo: Demonstrate the configured escalation rules, return of incomplete evidence and permissions. Confirm the actual reporting connection and included workflows; a published capability does not establish your configuration. Source: assurx.com

Also meet the rule, in the same order (8)

Demo case: one duplicate report and one new occurrence

Use a fictional product with a loose housing cover. CMP-017 is the customer's report about unit U-017 in lot L-04. CMP-018 arrives from its distributor; the reviewer confirms it concerns the same unit and event. Retain both source reports, receipt dates and the reason for linking them. Do not delete the distributor's evidence or count the same event twice in an event-based metric.

The support team sends a replacement and closes its ticket. The quality investigation remains open. Later, after action ACT-017 is implemented, CMP-019 reports the same symptom on a different unit, U-022 in lot L-05. It is a new occurrence to review, not a duplicate simply because the symptom matches. Include the recurrence in the pending effectiveness review; it does not by itself prove the same root cause.

CMP-020 lacks a unit and lot identifier. Preserve the allegation and assign follow-up for the missing context. Do not invent a batch match or mark the complaint invalid just because no returned sample is available. The reviewer should record what can be concluded from the evidence and what remains unknown.

Review the linked records without collapsing their meanings

Synthetic record	Demo evidence	Review needed
CMP-017 / U-017 / L-04	Customer report; replacement sent; support ticket closed	Keep the quality investigation and its outcome separate from customer-service closure.
CMP-018 / U-017 / L-04	Distributor report confirmed to concern the CMP-017 event	Preserve both reports and the reviewer link; count once only when the metric is unique events.
ACT-017	Action implementation complete; effectiveness review pending	Retain acceptance criteria, review timing and supporting evidence.
CMP-019 / U-022 / L-05	A later occurrence after ACT-017; same reported symptom	Assess the connection to the earlier investigation and the action's effectiveness.
CMP-020 / identifiers missing	An allegation with incomplete product traceability	Assign follow-up and retain uncertainty; do not silently merge it into another lot.

Ask for a reasoned escalation decision

Vendor documentation describes these connections in different places: one complaint page describes escalation to CAPA for systemic issues, while another vendor's CAPA documentation separately describes action ownership and effectiveness checks. Use such documented connections as demo starting points, not proof that every complaint should trigger the same path.

Have the reviewer explain an escalation decision using the available evidence, risk and your approved procedure. Also demonstrate a documented decision not to open a new CAPA, for example where a record is linked to an existing investigation. Preserve that reasoning and show how new evidence can prompt reassessment. An incomplete record or open CAPA should remain visible to the people responsible for the next decision.

Fewer complaints can still produce a higher rate

Use this separate, fictional trend dataset; its totals are not derived from the four case reports above. Define the numerator as reviewed unique complaint events and the denominator as units shipped in the same reporting window for the same product scope. Keep the report count and unique-event count available separately.

Window A has 5 events and 1,000 units shipped: 5 events per 1,000 units. Window B has 3 events and 100 units shipped: 30 events per 1,000 units. The raw count falls while this illustrative rate rises. A third window with no verified denominator has no calculable rate, not a zero rate.

This arithmetic is a reporting exercise, not a statistical signal, acceptance limit or proof that an action failed. Review reporting delays, exposure, product mix and the chosen denominator before drawing a conclusion; same-window shipments may not represent the units that generated the complaints. The software should retain those definitions with the chart.

Make the metric reproducible

Illustrative window	Unique events	Units shipped	Events per 1,000 units
A	5	1,000	5
B	3	100	30
C	2	Not verified	Not calculable

For medical devices, scope the reporting handoff explicitly

FDA states that the Quality Management System Regulation (QMSR) became effective on 2 February 2026. Use the applicable current framework when evaluating a device implementation. A vendor's generic compliance statement is not evidence that your configured process meets it.

FDA's medical-device reporting overview distinguishes reporting responsibilities and the evaluation of complaints for reportability. Have the responsible reviewer define the product, jurisdiction, reporting role and deadline basis, including how reporting work proceeds while an investigation remains open. This guide does not classify the fictional complaint as reportable.

A task to prepare a report, an eMDR form initiated from a quality system, and a successful electronic submission are different steps. Using FDA's eMDR resources, ask for the proposed test workflow: report preparation, authorization, transmission, response, error correction and retained evidence. US MDR reporting is distinct from the EU Medical Device Regulation; one interface does not establish the other.

The same FDA eMDR overview states that the ESG NextGen Unified Submission Portal replaced the legacy WebTrader interface on 14 April 2025. Where vendor material still uses the old label, ask for evidence of the currently supported connection and test environment; the wording alone does not establish either compatibility or incompatibility.

Six demonstrations with the same complaint records

Reconcile two reports of one event

Link CMP-017 and CMP-018 only after review. Preserve source content, receipt dates and the link rationale. Reverse an incorrect link and inspect the resulting history and counts.

Investigate incomplete evidence

Keep CMP-020's missing identifiers visible. Show how follow-up, evidence received later and reviewer conclusions are recorded without overwriting the original allegation.

Separate escalation and closure decisions

Close the customer-service response while quality work stays open. Demonstrate CAPA escalation and a reasoned no-new-CAPA decision, with authorization and links to any existing investigation.

Challenge effectiveness with recurrence

Implement ACT-017, revise its linked procedure and complete assigned training. Introduce CMP-019 afterward and require a fresh effectiveness review; a completed action or course is not the outcome evidence.

Reproduce the trend and reporting handoff

Calculate the two rates using the stated definitions and leave Window C unresolved. Where reporting is in scope, demonstrate a failed test submission and its recovery separately from complaint closure.

Export with the correct access

Use customer-service, quality-reviewer and external-contributor roles. Export the reports, links, decisions, attachments and history. Confirm configuration, validation responsibilities and interface/support costs in the quote.

Prepare the complaint demo scorecard

Start with the first products listed above and six editorial questions covering report identity, incomplete evidence, CAPA decisions, recurrence, trends/reporting and access/quote scope. These are proposed checks, not verified product outcomes; all results start as untested.

Start the complaint demo scorecard

Put the demonstrated configuration in the proposal

Name the complaint, CAPA, document/training and any reporting applications required; confirm the included versions and interfaces.

Specify who may submit, view sensitive information, link reports, approve an investigation and authorize a submission.

Confirm the actual CRM/ERP objects, transfer direction, duplicate handling, connection failures and support owner.

Test connectivity for intake, attachments and approvals separately. This review establishes no universal offline complaint workflow.

Include configuration changes, validation responsibilities, migration, evidence exports, retention and post-contract access.

Sources and limits of this guide

8 sources

Vendor pages establish documented application scope; FDA sources provide US medical-device context. The sample reports, actions and trend windows are fictional demo material. No product ranking, guaranteed compliance, universal CAPA trigger, reporting deadline or complaint-rate threshold is assigned. The linked profiles retain their earlier research dates; AssurX's editorial demo questions were revised for this exercise.

Software categories to explore

Use this Process to define the work, then explore these software types. Confirm the exact workflow and module with each vendor.

See all software categories

Root Cause Analysis for Incidents: 7 Methods Compared
Article on root cause analysis methods for incidents.
KPI (Key Performance Indicator) — definition, software & FAQs
Definition of a key performance indicator.
Nonconformance Report (NCR) Template
Free template for a nonconformance report.
Medical Device Complaint and CAPA Record Template
Free template for a medical device complaint and CAPA record.

Frequently Asked Questions

Is complaint software the same as a customer-service ticket system?

Their tasks can overlap, but customer communication and quality investigation are separate decisions. For a QHSE purchase, test product identifiers, evidence, review, CAPA links and any applicable reporting workflow, rather than using a closed support ticket as proof of completion.

Does every complaint require a CAPA?

Do not assume a separate CAPA for every record. Use the evidence, risk and approved escalation procedure, record the reviewer decision and preserve links to existing investigations. New evidence may require reassessment.

Are a complaint and a nonconformance the same thing?

A complaint reports an alleged problem. A nonconformance records failure to meet a requirement and can be identified through internal work or external information. Preserve the allegation, investigation and evidence supporting any confirmed finding as related records.

Should duplicate reports be deleted?

Retain the original source reports and the reviewer decision linking them. Define whether each metric counts reports, unique events or affected units, and demonstrate how an incorrect link can be corrected.

Does a lower complaint count prove improvement?

No. In the fictional trend exercise, 5 events among 1,000 shipped units gives 5 per 1,000, while 3 among 100 gives 30 per 1,000. Definitions, exposure, reporting delays and incomplete denominators still need review; this is arithmetic, not a statistical effectiveness criterion.

Does generating an FDA report prove submission is complete?

No. Distinguish reportability assessment, preparation, authorization, transmission, response and any correction. Scope the actual product, reporting role and jurisdiction; a form or task alone does not establish the complete reporting workflow.